OGC
BEAT

One68 Global Capital’s BioTelemetry, Inc. BEAT Stock Holding History

One68 Global Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$246K Buy
+3,413
New +$179K 0.49% 46

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

One68 Global Capital's BEAT Position: Q4 2020 in Review

One68 Global Capital opened a new position in BioTelemetry, Inc. (BEAT) in Q4 2020: 3,413 shares worth $246K. The stake represents 0.49% of the portfolio and ranks #46 among its holdings.

238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • One68 Global Capital held 3,413 shares of BioTelemetry, Inc. worth $246K as of Q4 2020.
  • BioTelemetry, Inc. was a new One68 Global Capital position in Q4 2020.
  • BioTelemetry, Inc. made up 0.49% of One68 Global Capital's portfolio in Q4 2020, its #46 holding.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.